Pursuing Cancer Immunology Drug Discovery Research at Takeda’s Research Center in Boston
If you are looking for specific information,please visit our country/region website.
This is the Heading
GO TO NEWSROOM
TSE Code 4502TSE 1st
FY2019 Q1 Financial Results Announcement (15:00 JST on July 31st, 2019)Conference Call on Financial Results 18:00 - 19:00 JSTPresenters: Christophe Weber, President & CEO, and others
IR Seminar “Plasma-Derived Therapies Business”(Held on July 12, 2019)
143rd Ordinary General Meeting of Shareholders (10:00 am JST on June 27, 2019)
Place: PACIFICO Yokohama, National Convention Hall
Offer for Shire plc
Copyright 1995-2019 Takeda Pharmaceutical Company Limited. All rights reserved.